Baseline characteristics of randomised participants
PKD: polycystic kidney disease, Kidney Disease
CEREBROVASCULAR ACCIDENT, KIDNEY DISEASE, MYOCARDIAL INFARCTION
The baseline charcteristics are presented in Tables 
Baseline demographic dataTotal number of available data (n), *mean and standard deviation, **median and interquartile ranges, number (n) or percentage (%) for all participants and for the two randomised groupsAbbreviations: BMI: body mass index, SBP: systolic blood pressure, DBP: diastolic blood pressure, CVA: cerebrovascular accident, MI: myocardial infarction, PKD: polycystic kidney disease, HBA1C: glycated haemoglobin, CRP: C-reactive Protein, Hb: haemoglobin, eGFR: estimated glomerular filtration rate, CFS: Clinical Frailty Scale
Baseline outcome measure dataTotal number of available data (n), *mean and standard deviation, **median and interquartile ranges [Q1,Q3], number (n) or percentage (%) for all participants and for the two randomized groups. Abbreviations: KDQoL: Kidney Disease Quality of Life, PHQ-4: Patient Health Questionnaire-4, WSAS: Work and Social Adjustment Scale, GPAQ: Global Physical Activity Questionnaire, MET: Metabolic Equivalent of Task, PAM: Patient Activation MeasureThe KDQoL SF1.3 MCS and PCS were similar in both groups. Likewise, the STS60 and the PAM scale were well matched.